N. Chalasani, Z. Younossi, J. E. Lavine, M. Charlton, K. Cusi et al., The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases, Hepatology, vol.67, issue.1, p.28714183, 2018.

P. Bedossa, C. Poitou, N. Veyrie, J. L. Bouillot, A. Basdevant et al., Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, Hepatology, vol.56, issue.5, p.22707395, 2012.

C. Soderberg, P. Stal, J. Askling, H. Glaumann, G. Lindberg et al., Decreased survival of subjects with elevated liver function tests during a 28-year follow-up, Hepatology, vol.51, issue.2, pp.595-602, 2010.

C. C. Park, P. Nguyen, C. Hernandez, R. Bettencourt, K. Ramirez et al., Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.152, issue.3, p.27911262, 2017.

R. Hernaez, M. Lazo, S. Bonekamp, I. Kamel, F. L. Brancati et al., Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, vol.54, issue.3, p.21618575, 2011.

S. Naveau, C. S. Voican, A. Lebrun, M. Gaillard, K. Lamouri et al., Controlled attenuation parameter for diagnosing steatosis in bariatric surgery candidates with suspected nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, vol.29, issue.9, p.28570343, 2017.

K. Imajo, T. Kessoku, Y. Honda, W. Tomeno, Y. Ogawa et al., Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography, Gastroenterology, vol.150, issue.3, p.26677985, 2016.

R. P. Myers, A. Pollett, R. Kirsch, G. Pomier-layrargues, M. Beaton et al., Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography, Liver Int, vol.32, issue.6, p.22435761, 2012.

D. E. Kleiner, E. M. Brunt, M. Van-natta, C. Behling, M. J. Contos et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.41, issue.6, p.15915461, 2005.

E. R. Delong, D. M. Delong, and D. L. Clarke-pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, vol.44, issue.3, p.3203132, 1988.

N. A. Obuchowski, M. J. Goske, and K. E. Applegate, Assessing physicians' accuracy in diagnosing paediatric patients with acute abdominal pain: measuring accuracy for multiple diseases, Stat Med, vol.20, issue.21, p.11746317, 2001.

J. Lambert, P. Halfon, G. Penaranda, P. Bedossa, P. Cacoub et al., How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited, Clin Chem, vol.54, issue.8, p.18539647, 2008.

J. Hintze, NCSS User's guide-I and User's guide-IV: number cruncher statistical systems, 2001.

R. Development-core and . Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2009.

V. De-ledinghen, J. Vergniol, M. Capdepont, F. Chermak, J. B. Hiriart et al., Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations, J Hepatol, vol.60, issue.5, p.24378529, 2014.

F. Shen, R. D. Zheng, J. P. Shi, Y. Q. Mi, G. F. Chen et al., Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease, Liver Int, vol.35, issue.11, p.25689614, 2015.

D. Ciocan, A. Lebrun, K. Lamouri, G. Pourcher, C. Voican et al., Adaptation of liver stiffness measurement depth in bariatric surgery candidates with suspected nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, vol.28, issue.9, p.27227687, 2016.

S. Audiere, M. Charbit, E. D. Angelini, J. Oudry, and L. Sandrin, Measurement of the skin-liver capsule distance on ultrasound RF data for 1D transient elastography, Med Image Comput Comput Assist Interv, vol.13, issue.2, p.20879296, 2010.

T. Karlas, D. Petroff, M. Sasso, J. G. Fan, Y. Q. Mi et al., Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis, J Hepatol, vol.66, issue.5, p.28039099, 2017.

V. De-ledinghen, J. B. Hiriart, J. Vergniol, W. Merrouche, P. Bedossa et al., Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan((R)): A Comparative Study with the M Probe and Liver Biopsy, Dig Dis Sci, vol.62, issue.9, p.28577247, 2017.

D. F. Ransohoff and A. R. Feinstein, Problems of spectrum and bias in evaluating the efficacy of diagnostic tests, N Engl J Med, vol.299, issue.17, pp.926-956, 1978.

V. De-ledinghen, G. L. Wong, J. Vergniol, H. L. Chan, J. B. Hiriart et al., Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease, J Gastroenterol Hepatol, vol.31, issue.4, p.26514665, 2016.

R. B. Merriman, L. D. Ferrell, M. G. Patti, S. R. Weston, M. S. Pabst et al., Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease, Hepatology, vol.44, issue.4, p.17006934, 2006.